Stronger authentication reduces the chance that prescriptions are issued through weak or shared credentials, which helps limit theft, fraud, and other misuse. When the authentication step is built into a unified workflow, clinicians can preserve fast access to records while adding verification where regulatory and patient-safety risk is highest. That balance is what makes adoption sustainable.
Why stronger authentication fits e-prescribing security
In e-prescribing, the main security gain comes from making it harder for an impostor or careless insider to act as a prescriber. Stronger sign-in reduces the value of stolen passwords, shared accounts, and weak recovery paths, so the prescription step is tied to a verified clinician rather than a reusable secret. That matters because medication ordering is a high-impact action, not just another login.
When authentication is designed around the actual prescribing workflow, it can add assurance without forcing clinicians into a separate security process for every chart lookup or clinical task. The practical goal is to raise assurance only at the point where the order is issued, signed, or transmitted, while keeping routine review and documentation fast enough for clinical use.
This is why good e-prescribing design usually distinguishes between access to information and authority to release medication orders. The more sensitive the action, the stronger the verification should be, especially where a weak credential could lead to diversion, fraud, or an unsafe prescription being processed as legitimate.
How to raise assurance without adding avoidable friction
The balance comes from placing stronger authentication where it changes the security outcome, not where it simply adds delay. Clinicians can often remain in a continuous session for reading records, but require step-up verification for signing a new prescription, changing a high-risk medication, or acting after a session timeout. That pattern preserves workflow speed while reducing the chance that a hijacked or unattended session can be used for harm.
A unified workflow also helps when the authentication method is supported by the prescribing application rather than bolted on as a separate portal. If the user can complete the necessary verification inside the same prescribing path, there is less chance of copy-and-paste workarounds, duplicated logins, or unsafe pressure to reuse shared credentials during busy shifts.
NIST SP 800-63 Digital Identity Guidelines is useful here because it frames authenticator strength, assurance levels, and phishing-resistant authentication in a way that supports higher-risk transactions without treating every screen as equal.
Why the clinical workflow still works when controls are stronger
Care delivery suffers when security controls interrupt the clinician at the wrong point. The right design keeps the low-friction tasks low-friction, then concentrates the stronger check on the event that actually creates downstream exposure, the prescription issuance itself. That means teams should think in terms of transaction risk, not blanket inconvenience.
In practice, the best results usually come from pairing stronger authentication with sensible session management, clear timeout behaviour, and recovery paths that do not silently weaken assurance. If account recovery or bypass procedures are easier than the prescribed login itself, the control becomes theatrical rather than protective. The workflow should feel predictable to clinicians and resistant to casual misuse by anyone who should not be issuing medication.
MFA Guide and Passwordless and Passkeys Guide both reinforce the same operational point: authentication should be strong enough to resist common bypasses, but simple enough that clinicians do not look for unofficial shortcuts.
Risk and Threat Considerations
Prescribing systems are attractive targets because a compromised account can create immediate patient-safety, fraud, and diversion impact. The main risk is not just unauthorized access, it is that a weak sign-in or shared credential can let an attacker issue or alter a prescription while appearing to be a legitimate clinician.
Failure mechanism: weak passwords, reused credentials, or inadequate step-up checks let an attacker, rogue insider, or unattended session reach the signing step without sufficient proof that the prescriber is actually present.
Impact: the result can be fraudulent dispensing, medication diversion, incorrect treatment, regulatory exposure, and operational disruption, especially if the workflow makes every signed order look trustworthy by default.
Microsoft Midnight Blizzard breach, Uber Breach, and Change Healthcare breach 2024 illustrate the same pattern: once authentication is bypassed or weakened, the attacker does not need to defeat the business process separately.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-63, OWASP ASVS and NIST SP 800-53 Rev 5 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-63 | Digital Identity Guidelines | E-prescribing depends on assurance levels and phishing-resistant auth for high-risk actions. |
| Recommendation — Use stronger authenticator assurance for prescription signing and keep routine chart access low friction. | ||
| OWASP ASVS | V6 — Authentication | The question is about strengthening authentication without disrupting the user workflow. |
| Recommendation — Require stronger authentication for sensitive prescribing actions and verify recovery paths. | ||
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | Clinician access to prescribing systems depends on authenticating organizational users before authorizing orders. |
| IA-5 — Authenticator Management | Credential lifecycle and authenticator handling are central to avoiding weak or shared login paths. | |
| Recommendation — Enforce strong clinician authentication before any prescription can be issued. Manage authenticators so shared, stale, or easily reused credentials are removed. | ||
| ISO/IEC 27001:2022 | A.5.17 — Authentication information | Prescribing security improves when authentication secrets and recovery data are controlled. |
| Recommendation — Protect authentication information and restrict how it is issued, stored, and recovered. | ||
Practitioner Guidance
What to prioritise: protect the prescribing action, not every click in the chart. If a control makes viewing harder but does little to secure signing, it is aimed at the wrong risk point.
What to verify: confirm that the stronger check is applied to order signing, high-risk medication changes, and recovery flows, not just to initial login. Also verify that shared accounts and fallback exceptions are tightly controlled, because those are where security intent usually erodes.
Decision rule: if a control can be bypassed through a weaker recovery path, treat the whole design as insufficient. The clinician experience should stay fast for routine work, but any path that authorizes medication should remain attributable to one person at one moment.
Practitioner takeaway: the safest e-prescribing design is not the one with the most login prompts, it is the one that adds proof exactly where prescribing authority is exercised and nowhere else.
Related resources from NHI Mgmt Group
- How should security teams design authentication analytics to improve user support and compliance without adding friction?
- How should security teams implement zero trust authentication without adding too much user friction?
- How should security teams implement stronger authentication without creating more user friction?
- How should security teams implement phishing-resistant authentication without hurting adoption?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 28, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
